World Intellectual Property (IP) Day is always an opportunity to reiterate the significance of the only property right protected in the Constitution. Celebrated every April 26, the festivities home in on a particular aspect of IP. The 2025 theme is “IP and Music: Feel the beat of IP.” Every nation has its own beat and […]
President Trump’s EO addresses the dual objectives of lowering drug prices while promoting innovation and protecting IP
The Biden-Harris administration’s latest attack on American innovation is aimed at artificial intelligence.
Intellectual property rights should be protected when artificial intelligence is used in creative works.
USPTO-FDA study reinforces the need to protect pharmaceutical intellectual property rights for the future of new drug development.
There is nothing more important to strengthening innovation than protecting and promoting intellectual property in healthcare.
On January 5, 2024, the U.S. FDA authorized Florida’s drug importation program.
The use of march-in rights to steal intellectual property will neither lower costs nor create more access to healthcare.
IRA drug price controls will devastate future drug development, resulting in more lives lost.
Pharmaceutical price controls in President Biden’s budget and the SMART Choices Act will devastate drug development.
